Susan O'Brien, MD

3:36

Drs. Susan O'Brien and Kieron Dunleavy discuss the rapidly evolving therapeutic landscape in chronic lymphocytic leukemia and the combinations of targeted agents and/or antibodies that are being evaluated for chemotherapy-free frontline therapy